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Background {#sec005}
==========

Intravascular catheters play an indispensable role in patient management. Peripheral venous catheters (PVC) are used increasingly in hospitals \[[@pone.0226251.ref001]--[@pone.0226251.ref004]\].

Proper maintenance of PVCs is essential if we are to prevent phlebitis, obstructions, and bacteremia \[[@pone.0226251.ref005]--[@pone.0226251.ref007]\]. A study review found that 10% (4,204) of 40,620 PVCs in 51 countries presented phlebitis \[[@pone.0226251.ref004]\].

A study in different departments of internal medicine in Spain collected phlebitis rates of 3.8--5.1% \[[@pone.0226251.ref008]\]

Maintenance requires periodic catheter locks with either heparin or saline in order to prevent complications. Heparin has proven efficacious specially in short term central venous catheters, which was slightly superior to saline for catheter locks \[[@pone.0226251.ref009]\]. However, its usefulness in PVCs remains controversial \[[@pone.0226251.ref010]--[@pone.0226251.ref016]\].

We compared the efficacy of saline and heparin locks in PVC maintenance in terms of phlebitis and catheter tip colonization rates.

Material and methods {#sec006}
====================

Setting {#sec007}
-------

Our institution is a general reference teaching hospital with 1,550 beds and approximately 55,000 admissions/year. Our Internal Medicine Department (IMD) is a 30-bed unit.

Study design {#sec008}
------------

We performed a prospective, randomized clinical trial over a period of 19 months (October 2015-October 2017). The authors confirm that all ongoing and related trials for this intervention are registered.

The study population comprised patients admitted to the IMD with at least 1 PVC. The patients who gave their informed consent were randomly assigned to 2 groups (1:1): saline (PosiFlush^®^, group A) or heparin (Fibrilin^®^, group B). Randomization was performed by the principal investigator of this project. A computer generates random number table was used to assign the groups. The envelopes were prepared by the principal investigator and consecutive numbered envelopes were generated containing the protocol and the assigned group to which patients would be included. Two groups of patients were chosen by a random procedure.

As the catheters of each patient were locked according to the group to which they belonged, the primary outcome measure was analyzed at catheter level, not at patient level. Therefore, the groups were not the same, as a patient can not have two catheters and that each catheter belonged to a different randomization group.

Inclusion and exclusion criteria {#sec009}
--------------------------------

The inclusion criteria were age ≥18 years, no evidence or suspicion of C-RBSI at enrolment, no history of allergy or intolerance to heparin, and no coagulation abnormalities.

The exclusion criteria were catheters inserted more than 24 hours.

Study medication {#sec010}
----------------

### Catheters with medication ≤24 hours {#sec011}

Group A: were flushed with 3 cc of saline (PosiFlush^®^) once per shift (each 8 hours).

Group B: were flushed with 60 units of heparin (Fibrilin^®^) once per day. Saline was flushed before it´s use according to the manufacturer´s recommendations.

### Catheters with medication ≥24 hours {#sec012}

Group A: were flushed with 3 cc of saline after each use.

Group B: were flushed with 60 units of heparin after each infusion. Saline was flushed before it´s use according to the manufacturer's recommendations.

### Catheter maintenance {#sec013}

Catheter care included the following: daily recording of the need for catheter use, daily monitoring of the insertion site, skin disinfection with 2% alcoholic chlorhexidine, connector disinfection with 70% alcohol wipes before use, hand hygiene, replacement of gauze/transparent dressing according to international guidelines, and use of split-septum closed connectors (CLAVE, ICU Medical, Inc., San Clemente, CA, USA) \[[@pone.0226251.ref017]\] \[[@pone.0226251.ref018]--[@pone.0226251.ref020]\]. PVCs were daily monitored by the nurse who cared them, and information was collected in the patient records.

Withdrawn catheters were included in the study and considered to belong to the group to which they had previously been randomized.

Patients were followed up until the catheter was removed or until discharge.

All catheters were withdrawn when clinically required, and the catheter tips, needleless connectors, and superficial cultures (skin and hub) were systematically sent for culture.

The study was registered at [www.clinicaltrials.gov](http://www.clinicaltrials.gov/) (NCT02970409).

Endpoints {#sec014}
---------

The primary endpoint was the frequency of phlebitis and/or catheter tip colonization rates in PVCs locked with either saline or heparin in patients admitted to the IMD.

The secondary endpoints were C-RBSI rate, catheter obstruction rate, indwelling time (days from insertion to withdrawal), adverse effects associated to heparin use such as bleeding or heparin-induced thrombocytopenia, hospital stay, and mortality rate.

### Definitions {#sec015}

[Phlebitis.]{.ul} Presence of 1 or more of the following criteria: swelling and erythema \>4 mm, tenderness, palpable venous cord, and pain or fever with local symptoms. Isolated swelling was not defined as phlebitis.

[Catheter tip colonization.]{.ul} Isolation of either ≥15 cfu/plate with the semiquantitative Maki technique or ≥100 cfu/segment with the sonication method.

[Skin and hub colonization.]{.ul} Isolation of ≥15 cfu/plate in semiquantitative culture.

[NC colonization.]{.ul} Isolation of ≥1 cfu/plate in at least 1 needless connector in the qualitative culture.

[C-RBSI.]{.ul} Isolation of the same microorganism both in the colonized PVC tip and in peripheral blood cultures.

Ethics {#sec016}
------

The Ethics Committee of our institution (Hospital Gregorio Marañon, number FIBHGM-ECNC 002--2014) approved the study on September 29, 2015. All patients gave their written informed consent to participate.

Statistical analysis {#sec017}
--------------------

Regarding the sample size calculation, considering that the rate of phlebitis in PVC was approximately 14% before beginning the study, we estimated that the sample size for the whole study should be 146 patients (a total of 292 catheters in each group, assuming that each patient has an average of two catheters), divided equally in each arm, in order to be able to detect a difference of 7% between the two groups with 80% power and a 5% level of significance.

Qualitative variables are expressed as their frequency distribution. Quantitative variables were expressed as the mean and standard deviation (SD) and as the median and interquartile range (IQR) if the distribution was skewed. Normally distributed continuous variables were compared using the Mann-Whitney test; non-normally distributed continuous variables were compared using the median test. The chi-squared or Fisher exact test was used to compare categorical variables. Statistical significance was set at p≤0.05.

A Kaplan-Meier analysis was conducted in the catheter group in order to assess the risk of phlebitis according to the indwelling time in each group.

Multiple logistic regression analysis was used to assess the risk of tip colonization. The variables included were: days of catheterization, hub colonization, skin colonization, insertion in the emergency department, and intervention group (saline vs. heparin).

We analyzed the data at two different categories: One as "intention to treat", which corresponds to those patients that were initially included in the study but that, at the end, the catheter tip could not be sent for culture. Therefore, it was imposible to analyze colonization in this group. And other as "by protocol", which corresponds to those patients of whom we had all the information regarding the catheter, and colonization rate could be assessed.

All other variables independent of catheter information could be analyzed in both groups.

The statistical analysis was performed using SPSS^®^ 21.0.

Results {#sec018}
=======

Study population {#sec019}
----------------

A total of 1,250 patients, were admitted to the IMD during the study period. Of these, 354 (464 catheters) were included in the study: 896 were excluded owing to lack of consent (40%), death, or indwelling time \>24 hours (60%), **[Fig 1](#pone.0226251.g001){ref-type="fig"}**.

![Patient flowchart.](pone.0226251.g001){#pone.0226251.g001}

### Analysis by intention to treat {#sec020}

A total of 464 PVCs from 354 patients were included. Of these, 250 (53.9%) were locked with saline (group A) and 214 (46.1%) were locked with heparin (group B).

**[Table 1](#pone.0226251.t001){ref-type="table"}** describes the characteristics of the study population (354). No significant differences were found between the groups in terms of main demographic characteristics.

10.1371/journal.pone.0226251.t001

###### Patients: Analysis of the study population based on intention to treat.

![](pone.0226251.t001){#pone.0226251.t001g}

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Intention to treat                                                                                                    Total\              SALINE\             HEPARIN\            p
                                                                                                                        N = 354             N = 181             N = 173             
  --------------------------------------------------------------------------------------------------------------------- ------------------- ------------------- ------------------- ------
  Median (IQR) [^a^](#t001fn001){ref-type="table-fn"} age in years                                                      79.0 (63.1--85.6)   80.5 (65.3--86.5)   78.4 (60.3--85.1)   0.22

  Sex, N (%)                                                                                                                                                                        0.66

      Male                                                                                                              155 (43.8)          77 (42.5)           78 (45.1)           

      Female                                                                                                            199 (56.2)          104 (57.5)          95 (54.9)           

  Underlying conditions, N (%)                                                                                                                                                      

      Myocardial infarction                                                                                             49 (13.8)           23 (12.7)           26 (15.0)           0.54

      Congestive heart failure                                                                                          139 (39.3)          77 (42.5)           62 (35.8)           0.23

      Central nervous system disease                                                                                    39 (11.0)           21 (11.6)           18 (10.4)           0.73

      Chronic obstructive pulmonary disease                                                                             96 (27.1)           50 (27.6)           46 (26.6)           0.90

      Renal dysfunction                                                                                                 72 (20.3)           39 (21.5)           33 (19.1)           0.59

      Diabetes mellitus                                                                                                 94 (26.6)           47 (26.0)           47 (27.2)           0.81

      Peptic ulcer disease                                                                                              28 (7.9)            15 (8.3)            13 (7.5)            0.84

      Peripheral vascular disease                                                                                       22 (6.2)            15 (8.3)            7 (4.0)             0.12

  Charlson, median (IQR) [^a^](#t001fn001){ref-type="table-fn"}                                                         3 (1--4)            3 (1--4)            2 (1--4)            0.94

  Apache II score, median (IQR) [^a^](#t001fn001){ref-type="table-fn"}                                                  6 (2.7--6.0)        6 (3.0--6.0)        6 (2.0--6.0)        0.21

      Median (IQR) DDDs [^b^](#t001fn002){ref-type="table-fn"}                                                          7 (4--129)          7 (4--11.6)         7.8 (4--12)         0.26

  Median (IQR) [^a^](#t001fn001){ref-type="table-fn"}length of hospital stay in days                                    7 (5.0--10.0)       7 (5--11.0)         7 (4.0--10.0)       0.33

  Median (IQR) [^a^](#t001fn001){ref-type="table-fn"}length of IM [^c^](#t001fn003){ref-type="table-fn"} stay in days   7 (4.0--9.0)        6 (4.0--9.5)        7 (4.0--9.0)        0.77

  Other infection, N (%)                                                                                                162 (45.7)          79 (43.6)           83 (48.0)           0.45

  Mortality, N (%)                                                                                                      19 (5.4)            14 (7.7)            5 (2.9)             0.06

  Episodes of C-RBSI [^d^](#t001fn004){ref-type="table-fn"}, N (%)                                                      1 (0.3)             1 (0.6)             0 (0.0)             1.00
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ IQR: interquartile range

^b^DDDs: daily defined doses

^c^ IM: internal medicine

^d^ C-RBSI: catheter-related bloodstream infection.

**[Table 2](#pone.0226251.t002){ref-type="table"}** describes the catheters per intention to treat (464). The median (IQR) indwelling time was 5 (3--8) days for both groups (p = 0.64). The frequency of phlebitis in groups A and B was 17.6% and 12.6%, respectively (p = 0.15).

10.1371/journal.pone.0226251.t002

###### Catheters per intention to treat.

![](pone.0226251.t002){#pone.0226251.t002g}

  --------------------------------------------------------------------------------------------------------------------
  Catheters                                                           Total\       Saline\      Heparin\     P value
                                                                      N = 464      N = 250      N = 214      
  ------------------------------------------------------------------- ------------ ------------ ------------ ---------
  Insertion site, N (%)                                                                                      

      Emergency department                                            349 (75.2)   182 (72.8)   167 (78.0)   0.19

  Location, N (%)                                                                                            

      Hand                                                            33 (7.1)     18 (7.2)     15 (7.0)     1.00

      Arm                                                             409 (88.1)   221 (88.4)   188 (87.9)   0.88

  Forearm                                                             22 (4.7)     11 (4.4)     11 (5.1)     0.82

  Use, N (%)                                                                                                 

      Parenteral nutrition                                            4 (0.8)      2 (0.8)      2 (0.9)      1.00

      Fluids                                                          17 (3.7)     10 (4.0)     7 (3.3)      0.80

      Antibiotics                                                     296 (63.8)   160 (64.0)   136 (63.6)   0.92

      Other                                                           147 (31.7)   78 (31.2)    69 (32.2)    0.84

  Reasons for catheter withdrawal, N (%)                                                                     

      End of use                                                      332          172 (68.8)   160 (74.8)   0.18

      Suspicion of infection                                          71           44 (17.6)    27 (12.6)    0.15

      Obstruction                                                     34           23 (9.2)     11 (5.1)     0.10

      Other                                                           21           9 (3.6)      12 (5.6)     0.37

  Phlebitis, N (%)                                                    71           44 (17.6)    27 (12.6)    0.15

  Median (IQR) [^a^](#t002fn001){ref-type="table-fn"} catheter-days   5 (3--8)     5.5 (3--8)   5.0 (3--8)   0.64

  Total catheter days                                                 2,903        1,580        1,323        \--
  --------------------------------------------------------------------------------------------------------------------

^a^ IQR, interquartile range.

No adverse effects were recorded.

Analysis per protocol {#sec021}
---------------------

A total of 339 PVCs (241 patients) were finally sent for culture: 192 (56.6%) in the saline group and 147 (43.4%) in the heparin group.

**[Table 3](#pone.0226251.t003){ref-type="table"}** describes the characteristics of the population per protocol (241). The per protocol analysis revealed no significant differences between the groups in terms of the main demographic characteristics.

10.1371/journal.pone.0226251.t003

###### Analysis of the study population per protocol.

![](pone.0226251.t003){#pone.0226251.t003g}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Per protocol                                                                                                           Total\              SALINE\             HEPARIN\            p
                                                                                                                         N = 241             N = 130             N = 111             
  ---------------------------------------------------------------------------------------------------------------------- ------------------- ------------------- ------------------- ------
  Median (IQR) [^a^](#t003fn001){ref-type="table-fn"} age in years                                                       78.7 (61.3--85.5)   78.7 (61.6--85.3)   78.5 (60.7--85.6)   0.98

  Sex, N (%)                                                                                                                                                                         0.43

      Male                                                                                                               106 (44.0)          54 (41.5)           52 (46.8)           

      Female                                                                                                             135 (56.0)          76 (58.5)           59 (53.2)           

  Underlying conditions, N (%)                                                                                           36 (14.9)                                                   

      Myocardial infarction                                                                                              90 (3.7)            16 (12.3)           20 (18.0)           0.27

      Congestive heart failure                                                                                           25 (10.4)           50 (38.5)           40 (36.0)           0.78

      Central nervous system disease                                                                                     73 (30.3)           12 (9.2)            13 (11.7)           0.53

      Chronic obstructive pulmonary disease                                                                              48 (19.9)           38 (29.2)           34 (30.6)           0.88

      Renal dysfunction                                                                                                  65 (27.0)           26 (19.8)           22 (20.0)           1.00

      Diabetes mellitus                                                                                                  18 (7.5)            31 (23.8)           34 (30.6)           0.24

      Peptic ulcer disease                                                                                               18 (7.5)            9 (6.9)             9 (8.2)             0.80

      Peripheral vascular disease                                                                                                            13 (10.0)           5 (4.5)             0.14

  Charlson, median (IQR)[^a^](#t003fn001){ref-type="table-fn"}                                                           3 (1--4)            2.5 (1--4)          3.0 (1--4)          0.41

  Apache II score, median (IQR) [^a^](#t003fn001){ref-type="table-fn"}                                                   6 (2--6)            6 (2.7--6)          6 (2--6)            0.92

  Median (IQR) [^a^](#t003fn001){ref-type="table-fn"} DDDs [^b^](#t003fn002){ref-type="table-fn"}                        7 (4--12)           7 (4--11.7)         8 (5--12)           0.25

  Median (IQR) [^a^](#t003fn001){ref-type="table-fn"} length of hospital stay in days                                    7 (5.0--10.0)       7 (5.0--11.0)       7 (5.0--10.0)       0.46

  Median (IQR) [^a^](#t003fn001){ref-type="table-fn"} length of IM [^c^](#t003fn003){ref-type="table-fn"} stay in days   7 (5.0--9.0)        7 (.0--10.0)        7 (4.0--9.0)        0.77

  Other infection, N (%)                                                                                                 115 (47.7)          59 (45.4)           56 (50.5)           0.44

  Mortality, N (%)                                                                                                       12 (4.9)            8 (6.2)             4 (3.6)             0.55

  Phlebitis, N (%)                                                                                                       51 (21.2)           30 (23.1)           21 (18.9)           0.26

  Episodes of C-RBSI [^d^](#t003fn004){ref-type="table-fn"}, N (%)                                                       0 (0.0)             0 (0.0)             0 (0.0)             NA
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ IQR: interquartile range

^b^DDDs: daily defined doses

^c^ IM: internal medicine

^d^ C-RBSI: catheter-related bloodstream infection.

**[Table 4](#pone.0226251.t004){ref-type="table"}** describes the catheters per protocol (339). The median (IQR) number of catheter days was 5 (3--8) for both groups (p = 0.54). The rate of phlebitis between the catheters from groups A and B was 21.9% (42/192) and 17.0% (25/147), respectively (p = 0.27). The rate of colonization of PVC tips was 14.6% (28/192) and 12.2% (18/147) in groups A and B, respectively (p = 0.63). There were only 2 episodes of C-RBSI; both occurred in a patient in group A.

10.1371/journal.pone.0226251.t004

###### Catheters per protocol.

![](pone.0226251.t004){#pone.0226251.t004g}

  --------------------------------------------------------------------------------------------------------------------
  Catheters                                                           Total\       Saline\      Heparin\     P value
                                                                      N = 339      N = 192      N = 147      
  ------------------------------------------------------------------- ------------ ------------ ------------ ---------
  Insertion place, N (%)                                                                                     

      Emergency department                                            236 (69.6)   131 (68.2)   105 (71.4)   0.55

  Location, N (%)                                                                                            

      Hand                                                            31 (9.1)     17 (8.9)     14 (9.5)     0.85

      Arm                                                             289 (85.2)   165 (85.9)   124 (84.4)   0.75

      Forearm                                                         19 (5.6)     10 (5.2)     9 (6.1)      0.81

  Use of catheter, N (%)                                                                                     

      Parenteral nutrition                                            3 (0.88)     2 (1.0)      1 (0.7)      1.00

      Fluids                                                          12 (3.5)     6 (3.1)      6 (4.1)      0.77

      Antibiotics                                                     221 (65.2)   129 (67.2)   92 (62.1)    0.42

      Medication                                                      103 (30.4)   55 (28.6)    48 (32.7)    0.47

  Reasons for catheter withdrawal, N (%)                                                                     

      End of use                                                      238 (70.2)   126 (65.6)   112 (76.2)   0.04

      Suspicion of infection                                          67 (19.8)    42 (21.9)    25 (17.0)    0.27

      Obstruction                                                     31 (9.1)     22 (11.5)    9 (6.1)      0.12

      Other                                                           3 (0.9)      2 (1.0)      1 (0.7)      1.00

  Median (IQR) [^a^](#t004fn001){ref-type="table-fn"} catheter-days   5 (3--8)     5 (3--8)     5 (3--8)     0.54

  Total catheter days                                                 2,019        1,142        877          NA

  Phlebitis, N (%)                                                    97 (28.6)    42 (21.9)    25 (17.0)    0.27

  Positive cultures, N (%)                                                                                   

  Tip colonization                                                    46 (13.6)    28 (14.6)    18 (12.2)    0.63

      Density per 1,000 catheter days                                 22.8         24.5         20.5         0.66

  Skin colonization                                                   64 (18.9)    40 (20.8)    24 (16.3)    0.32

      Density per 1,000 catheter days                                 31.7         35.0         27.4         0.41

  Hub colonization                                                    21 (6.2)     15 (7.8)     6 (4.1)      0.12

      Density per 1,000 catheter days                                 10.4         13.1         6.8          0.24

  NCT [^b^](#t004fn002){ref-type="table-fn"} colonization             76 (22.4)    41 (21.4)    35 (23.8)    0.60

      Density per 1,000 catheter days                                 37.6         35.9         39.9         0.73

  Episodes of C-RBSI [^c^](#t004fn003){ref-type="table-fn"}, N (%)    2 (0.6)      2 (1.0)      0 (0.0)      0.50
  --------------------------------------------------------------------------------------------------------------------

^a^IQR: interquartile range

^b^NCT: needleless connector

^c^C-RBSI: catheter-related bloodstream infection.

We did not find differences between the groups with respect to the etiology of colonization (**[Fig 2](#pone.0226251.g002){ref-type="fig"}**).

![Etiology of the colonized catheters.](pone.0226251.g002){#pone.0226251.g002}

The skin was colonized in 22% of the 236 PVCs inserted in the emergency department (p = 0.01).

**[Table 5](#pone.0226251.t005){ref-type="table"}** describes multivariate logistic regression analysis of tip colonization. Logistic regression analysis revealed colonization of skin and hubs as the only independent risk factors for catheter tip colonization.

10.1371/journal.pone.0226251.t005

###### Multivariate logistic regression analysis of tip colonization.

![](pone.0226251.t005){#pone.0226251.t005g}

                                      Odds ratio   β      p-value   95% CI
  ----------------------------------- ------------ ------ --------- ---------------
  Insertion in emergency department   1.24         0.21   0.72      0.37--4.14
  Group (saline/heparin)              1.51         0.41   0.40      0.56--4.02
  Skin colonization                   92.26        4.52   \<0.001   28.35--300.18
  Hub colonization                    25.97        3.25   \<0.001   4.63--145,7
  Catheter days                       1.04         0.04   0.54      0.90--1.20

The Kaplan-Meier analysis did not reveal statistically significant differences for phlebitis according to the days of catheter in each group (long-rank test p = 0.19), **[Fig 3](#pone.0226251.g003){ref-type="fig"}**.

![Kaplan-Meier analysis of the risk of phlebitis according to catheter days.](pone.0226251.g003){#pone.0226251.g003}

Discussion {#sec022}
==========

We found no significant differences regarding phlebitis and catheter tip colonization rates in PVCs locked either with saline or heparin.

The increasing use of PVCs results in a rate of infection similar to that of central venous catheters when these catheters are monitored \[[@pone.0226251.ref005],[@pone.0226251.ref006]\]. However, recommended preventive measures, such as using heparin locks for catheter maintenance, are not as rigorous as those recommended for central venous catheters \[[@pone.0226251.ref017],[@pone.0226251.ref021]\]. This issue remains controversial because of the lack of randomized controlled trials and the heterogeneous results reported \[[@pone.0226251.ref010],[@pone.0226251.ref022]\].

We proved that is not necessary to lock PVCs with heparin, as phlebitis and catheter tip colonization rates were similar for PVCs locked with saline and PVCs locked with heparin. Our findings are similar to those of other studies comparing saline and heparin in the maintenance of PVCs: we found no statistically significant differences between the groups regarding catheter obstruction rate, indwelling time, phlebitis, and accidental catheter removal \[[@pone.0226251.ref022]\] \[[@pone.0226251.ref010],[@pone.0226251.ref016]\]. On the other hand, indwelling time has been reported to be longer in PVCs locked with heparin \[[@pone.0226251.ref023]\]. A systematic review and meta-analysis examining catheter maintenance showed that continuous infusion of heparin in PVCs improved the duration of patency and reduced infusion failure and phlebitis. However, no statistically significant differences were found when heparin was used intermittently, which is the usual protocol for catheter locking \[[@pone.0226251.ref022]\].

Our study revealed the frequency of phlebitis to be 28.6%, which was similar to percentages reported elsewhere (9%-33%) \[[@pone.0226251.ref007],[@pone.0226251.ref024],[@pone.0226251.ref025]\].

In addition, our data showed that catheter insertion in the emergency department was associated with high skin colonization and phlebitis rates, as reported elsewhere \[[@pone.0226251.ref026],[@pone.0226251.ref027]\]. Therefore, when it is not possible to ensure adherence to guidelines by the personnel inserting catheters in the emergency room, catheters should be replaced within 48 hours.

Despite it was no statistical significance, we found a difference between mortality rate in both groups. However, we consider that it may have no impact in the study endpoints. We also had very difficult to include patients in this study because many patients came from the emergency room with the peripheral venous catheter inserted more than 24 hours.

Our study is subject to limitations, and our results must be interpreted with caution. We were unable to identify the number of flushes performed for each catheter or to assess whether the nurses who inserted the catheter had received appropriate training. In addition, since we only enrolled patients from the IMD, our data cannot necessarily be extrapolated to other populations.

Another limitation was that, despite the tip could not be collected in many patients for different reasons and it reduce the sample size, we did not find significant differences between both groups.

While it is recommended to use a 10-mL diameter syringe and prefilled flush syringes, flushing practices for PVCs appear to vary widely. Therefore, we consider it is necessary to perform future studies to standardize volumes and frequency of flushing for the maintenance of PVCs \[[@pone.0226251.ref012],[@pone.0226251.ref014],[@pone.0226251.ref015],[@pone.0226251.ref028]\].

To conclude, we consider that PVCs can be locked with saline for maintenance, as this is safer and cheaper than heparin.

We thank Thomas O'Boyle for his help in the preparation of the manuscript.
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